期刊文献+

急性颈髓损伤血浆NSE含量与损伤程度的相关性 被引量:1

The correlation between the neuron-specific enolase quantity and acute cervical spinal cord injury
下载PDF
导出
摘要 目的探讨急性颈髓损伤后血浆神经元特异性烯醇化酶(NSE)含量的动态变化在评估病情严重程度的相关价值。方法从2010年3月至2012年3月,收集急性颈髓损伤60例,根据ASIA评分,分 A、B、C、D、E级。采集损伤后24小时内、48小时、72小时、7天的静脉血2ml,使用双抗体夹心型电化学发光法,测定血浆NSE的水平,并选择60例对照组比较,观察其动态变化。结果急性颈髓损伤患者血浆NSE 含量较对照组有升高(P<0.05),主要表现在A、B级。约72小时时达高峰,随后下降,7天时恢复至正常水平。损伤评级高(越接近 A 级),血浆NSE 峰值越高。结论血NSE可作为急性颈髓损伤评估病情严重程度的监测指标。 Objective To investigate the plasma neuron-specific enolase (NSE) dynamic changes in the severity assessment of the acute cer- vical spinal cord injury (ACSCI) . Methods From Sept. 2007 to Sept. 2010, 60 patients with ACSCI were collected and 60 volunteers were recruit- ed as controls in the study. According to ASIA's score, the patients were divided into A, B, C, D, E level. 2 ml venous blood was taken, double anti- body sandwich type electrochemical luminescence method was used to measure the NSE quantity, the dynamic changes was observed Results The level of NSE was significantly higher in the patients with ACSCI than that in the control group (P〈0.05), mainly in the A and B group. The peak NSE level occt/red at about 72 h, and then decreased, reached normal level at 7 d. The more severe the damage was (closer to A level), the higher the peak NSE level. Conclusion The level of NSE can be considered as an indicator to assess the severity of acute cervical sninal cord injury.
出处 《浙江创伤外科》 2012年第6期721-722,725,共3页 Zhejiang Journal of Traumatic Surgery
基金 温州市医药卫生科研项目(2011A002)
关键词 急性颈髓损伤 神经元特异性烯醇化酶 Acute cervical spinal cord injury Neuron-specific enolase
  • 相关文献

参考文献12

二级参考文献74

  • 1藏磊,刘忠军,党耕町,刘晓光.无骨折脱位型颈脊髓损伤再手术原因分析[J].中国脊柱脊髓杂志,2004,14(5):268-270. 被引量:15
  • 2刘晓光,刘忠军,党耕町.脊髓损害中内皮素的变化[J].中华骨科杂志,1996,16(7):460-461. 被引量:13
  • 3范理宏,蔡映云.神经内分泌分化与非小细胞肺癌[J].肿瘤,2006,26(6):579-581. 被引量:6
  • 4陈长青,练克俭,贾连顺,李家顺.猪胸腰段脊髓火器贯通伤后神经元特异性烯醇化酶的早期表达[J].脊柱外科杂志,2006,4(4):229-232. 被引量:5
  • 5Gumnarsson T, Fehlings MG.Acute neuro surgical managemcut of traumatic brain niury and spinal cord niury[J].curtopin Neurol,2003,16(6):717-719.
  • 6Howe MG,Chapman A,Kerr K,et al.Nenroendocrine differentiation in non-small cell lung cancer and its relation to prognosis and therapy[J].Histopathology,2005,46(2):195-201.
  • 7Walker GE.Antoniono RJ,Ross HJ,et al.Neuroendocrine-like differentiation of non-small cell lung carcinoma cells:regulation by cAMP and the interaction of mac25/IGFBP-rP1 and 25.1[J].Oncogene,2006,25(13):1943-1954.
  • 8Tavassolia F,Devilee P.World Health Organization classification of tumors Pathology and genetics tumors of the breast and female genital organs[M].Lyon:IARC Press,2003.32-34.
  • 9Slodkowska J,Zych J,Szturmowicz M,et al.Nenrocndocrine phenotypc of non-small cell lung carcinoma:immunohistological evaluation and biochemical study[J].Int J Biol Narkers,2005,20(4):217-226.
  • 10Sφrhaug S,Steinsbamn S,Haaverstad R,et al.Expression of neuroendocrine markers in non-small.cell lung cancer[J].APMIS,2007,115(2):152-163.

共引文献56

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部